#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Duchenne muscular dystrophy Plasma cell myeloma Malignant neoplasm of choroid Deafness Fabry's disease Neurodermatitis Cystic fibrosis respiratory infection suppression Alexander disease Cutaneous T-cell lymphoma stage II Human papilloma virus immunisation Hereditary spastic paraplegia Chondrosarcoma metastatic Neuroendocrine tumour of the lung Autoimmune haemolytic anaemia Pancreatic neuroendocrine tumour More trials…

    Learn about Rare Diseases

    Sjogren’s syndrome Lymphangioma – Trials in Disease Glycogen storage disease type I – Life with Disease Ehlers-Danlos syndrome – Trials in Disease Langerhans’ cell histiocytosis – Basic Information Pulmonary sarcoidosis – Trials in Disease Hepatoblastoma – Trials in Disease Marginal zone lymphoma – Life with Disease Isodicentric chromosome 15 syndrome – Life with Disease Ornithine transcarbamoylase deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alternaria Alternata Extract Pyridoxine Hydrochloride Bp Benzocaine Indometacin Ph. Eur. Morphine Sulfate Psilocybine Indocyanine Green Exenatide ZUNIBERGENE ROCPARVOVEC Loperamide Hydrochloride VANDETANIB Parsaclisib Hydrochloride SODIUM SULFIDE NONAHYDRATE Bimekizumab Roxadustat Wt1/Il15/Il15Ra Mrna Dc Argatroban Monohydrate Vosoritide Telmisartan Auto4 More therapies…

    Learn about Your Condition

    Plasmablastic lymphoma Renal impairment Lip and/or oral cavity cancer Hyperchylomicronaemia Ovarian granulosa cell tumour Pruritus Acute myocardial infarction Stevens-Johnson syndrome Prolymphocytic leukaemia Peritoneal cancer index Thermal burn Radiation skin injury Aplastic anaemia Hernia repair Frostbite More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Gliclazide
    • Metformin
    • Dapagliflozin
    Bulgaria Hungary Latvia Lithuania Poland

  • Study on AZD2693 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis and PNPLA3 Genetic Marker

    Not recruiting

    2 1
    Investigated Drugs:
    • Azd2693 Sodium
    Germany Italy Spain

  • Study on Long-Term Safety and Efficacy of ARO-APOC3 for Adults with Mixed Dyslipidemia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type V hyperlipidaemia
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Hungary The Netherlands Poland

  • Study of pegvaliase injections compared to diet control in adolescents aged 12-17 with phenylketonuria (PKU)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Phenylketonuria
    Investigated Drugs:
    • Pegvaliase
    Germany

  • Study to Evaluate mRNA-3210 for Safety and Tolerability in Patients with Phenylketonuria

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Phenylketonuria
    Investigated Drugs:
    • Fexofenadine
    • Hydroxyzine Hydrochloride
    • Ibuprofen Lysine
    France Italy Spain

  • Study of LY3502970 for Adults with Obesity or Overweight and Related Health Issues

    Not recruiting

    3 1
    Slovakia Spain
Previous Page
1 … 50 51 52 53 54 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!